Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database

QOL data will be collected at baseline (pre-transplant), 100 days, 6 months, and 12 months
post transplant. The transplant center will consent the patient and administer the baseline
QOL surveys. The transplants center will then submit the competed baseline data and patient
contact information to the Center for International Blood and Marrow Transplant Research
(CIBMTR). The remaining surveys will be administered to the patient from the CIBMTR via paper
surveys mailed to the patient.

Inclusion Criteria:

1. Adult (≥ 18 years), or pediatric (≥ 2 years and < 18 years) allogeneic HCT recipient
(related, unrelated, or CBU) at participating pilot study transplant centers.

2. Signed informed consent form from adult patient or parent/guardian of pediatric
patient.

3. Patient must have a valid mailing address within the United States to receive QOL
surveys.

4. Ability to speak and read English.

5. Patients with access to a telephone.